Literature DB >> 13410191

Studies on the diethylamide of lysergic acid (LSD-25). II. Effects of chlorpromazine, azacyclonol, and reserpine on the intensity of the LSD-reaction.

H ISBELL, C R LOGAN.   

Abstract

Entities:  

Keywords:  AZACYCLONOL/effects; CHLORPROMAZINE/effects; LYSERGIC ACID DIETHYLAMIDE; MENTAL DISORDERS/therapy; RESERPINE/effects

Mesh：

Substances：

Year:  1957        PMID： 13410191     DOI： 10.1001/archneurpsyc.1957.02330340026002

Source DB:  PubMed          Journal:  AMA Arch Neurol Psychiatry        ISSN： 0096-6886


× No keyword cloud information.
  7 in total

1.  Some aspects of the effects of acute reserpine treatment on behaviour.

Authors:  P H GLOW
Journal:  J Neurol Neurosurg Psychiatry       Date:  1959-02       Impact factor: 10.154

2.  LSD as an agonist at mesolimbic dopamine receptors.

Authors:  P H Kelly; L L Iversen
Journal:  Psychopharmacologia       Date:  1975-12-31

Review 3.  The abuse potential of medical psilocybin according to the 8 factors of the Controlled Substances Act.

Authors:  Matthew W Johnson; Roland R Griffiths; Peter S Hendricks; Jack E Henningfield
Journal:  Neuropharmacology       Date:  2018-06-05       Impact factor: 5.250

4.  Possible involvement of the central dopaminergic system in the antireserpine effect of LSD.

Authors:  M K Menon; W G Clark; D T Masuoka
Journal:  Psychopharmacology (Berl)       Date:  1977-05-09       Impact factor: 4.530

5.  Serotonergic Psychedelics: Experimental Approaches for Assessing Mechanisms of Action.

Authors:  Clinton E Canal
Journal:  Handb Exp Pharmacol       Date:  2018

6.  Comparison of the action of lysergic acid diethylamide and apomorphine on the copulatory response in the female rat.

Authors:  M Eliasson; B J Meyerson
Journal:  Psychopharmacology (Berl)       Date:  1976-09-29       Impact factor: 4.530

7.  Dissociation of multiple effects of acute LSD on exploratory behavior in rats by ritanserin and propranolol.

Authors:  S M Mittman; M A Geyer
Journal:  Psychopharmacology (Berl)       Date:  1991       Impact factor: 4.530
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.